AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
In hot venture capital year, local new biotechs sizzle.
Byline: Bruce V. Bigelow
Jan. 23--Amid a nationwide surge in venture capital funding for health care technologies, two San Diego biotechnology companies ranked among the top 10 deals in the last three months of 2006.
A $100 million investment in Kalypsys ranked as the single biggest deal nationwide during the fourth quarter, and propelled San Diego to a strong finish for the year, based on separate surveys released yesterday.
Another San Diego biotech, Verus Pharmaceuticals, also placed in the top 10 with a $55 million deal, based on data released by PricewaterhouseCoopers, the National Venture Capital Assocation and Thomson Financial.
Those two deals accounted for more than 40 percent of the $380.2 million invested in San Diego startups during the …
-
- Slowdown in venture capital seen in San Diego.
-
News wire article from: The San Diego Union-Tribune (San Diego, CA)
January 24, 2006
700+ words
-
- San Diego-area venture capital funding on upswing.
-
News wire article from: The San Diego Union-Tribune (San Diego, CA)
July 27, 2004
700+ words
-
- Venture capital veteran starts tech, science fund in San Diego.
-
News wire article from: The San Diego Union-Tribune (San Diego, CA)
November 24, 2004
700+ words
-
- Venture capital consultant opens office in San Diego.
-
News wire article from: The San Diego Union-Tribune (San Diego, CA)
December 14, 2004
700+ words
-
- Surveys Differ on Venture Capital Investments in San Diego Area.
-
News wire article from: The San Diego Union-Tribune (San Diego, CA)
October 28, 2003
700+ words
